14G2a / 14.G2a
| Antibody ID | AN0157 |
|---|
| Epitope ID | EP0061 |
|---|---|
| Epitope name | GD2 |
| Recognition region | GalNAc(b1-4)[Neu5Ac(a2-8)Neu5Ac(a2-3)]Gal(b1-4)Glc(b1-1)Cer |
| Immunoprecipitation | |
| Immunoblot | [2][3][1] |
| ELISA/RIA | [1] |
| Flow cytometry | |
| Histochemistry | [4][5][6][1] |
| Comment |
| Species | Mouse |
|---|---|
| Category | Monoclonal |
| Isotype | IgG2a |
| Immunogen | |
| Availability | Becton, Dickinson and Company Santa Cruz Biotechnology, Inc. Millipore |
| Applications |
| 1 | Ravindranath MH, Muthugounder S, Presser N, Selvan SR, Portoukalian J, Brosman S, Morton DL. Gangliosides of organ-confined versus metastatic androgen-receptor-negative prostate cancer. Biochem Biophys Res Commun. 2004 Nov 5;324(1):154-65 PMID: 15464996 |
|---|---|
| 2 | Sen G, Chakraborty M, Foon KA, Reisfeld RA, Bhattacharya-Chatterjee M. Preclinical evaluation in nonhuman primates of murine monoclonal anti-idiotype antibody that mimics the disialoganglioside GD2. Clin Cancer Res. 1997 Nov ;3(11):1969-76 PMID: 9815586 |
| 3 | Sen G, Chakraborty M, Foon KA, Reisfeld RA, Bhattacharya-Chatterjee MB. Induction of IgG antibodies by an anti-idiotype antibody mimicking disialoganglioside GD2. J Immunother. 1998 Jan ;21(1):75-83 PMID: 9456440 |
| 4 | Lode HN, Handgretinger R, Schuermann U, Seitz G, Klingebiel T, Niethammer D, Beck J. Detection of neuroblastoma cells in CD34+ selected peripheral stem cells using a combination of tyrosine hydroxylase nested RT-PCR and anti-ganglioside GD2 immunocytochemistry. Eur J Cancer. 1997 Oct ;33(12):2024-30 PMID: 9516847 |
| 5 | Vriesendorp FJ, Quadri SM, Flynn RE, Malone MR, Cromeens DM, Stephens LC, Vriesendorp HM. Preclinical analysis of radiolabeled anti-GD2 immunoglobulin G. Cancer. 1997 Dec 15;80(12 Suppl):2642-9 PMID: 9406719 |
| 6 | Yuki N, Yamada M, Tagawa Y, Takahashi H, Handa S. Pathogenesis of the neurotoxicity caused by anti-GD2 antibody therapy. J Neurol Sci. 1997 Aug ;149(2):127-30 PMID: 9171318 |